to Content
Header Image

01: From basic research to economic value

-
Hauptschule
Breakout / Working Group
in englischer Sprache

In today s economic world knowledge, especially technological and scientific knowledge is becoming the most important factor for the success of an economy. Universities and research institutions are producers and owners of this knowledge, parts of which have to be patented and protected. In an institution dedicated to excellent basic research, the financial exploitation of intellectual property must be secondary to the main goal of the organisation. On the other hand, a modern university or research institution has to take care to market the resulting intellectual property rights as ‘by-products’ of basic research in a professional way, thus deriving another source of income for basic research and thus contribute to the economy. By discussing three topics – (i) Improving technology transfer, (ii) Are conflicts of interest between basic research and technology transfer unavoidable? (iii) Start-ups from academic research institutions – we will try to provide the participants with expert knowledge from the daily practice.

Austrian Federal Minister for Education, Vienna
Senior Associate Provost and Chief Technology Development Officer, Office of Technology Development, Harvard University, Cambridge
Director of Technology Transfer, The Tech Transfer Unit, University of Copenhagen
Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich
Member of the French Academy of Sciences; Director General, PALUMED, Labège
CEO & President, Femtolasers Produktions GmbH, Wien
Nobelpreisträger für Physik; Professor emeritus, Institut für Festkörperforschung, Forschungszentrum Jülich GmbH, Jülich Comment
Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot Chair
Head of Corporate Technology Central Eastern Europe (CEE), Siemens AG Österreich, Vienna Coordination

Dr. Sonja HAMMERSCHMID

Austrian Federal Minister for Education, Vienna

1990-1995 Wissenschaftliche Mitarbeiterin, Boehringer Ingelheim Austria GmbH
1995-1997 Wissenschaftliche Mitarbeiterin, Universität Wien (Postdoc)
1998-1999 Produktmanagerin bei Margaritella-Biotrade GmbH
1999-2005 Leiterin von Life Science Austria bei der Innovationsagentur GmbH (seit 2003 aws)
2000-2010 Investmentmanagerin der UniVenture Fonds
2002-2005 Geschäftsführerin, ARGE LISA Vienna Region
2003-2010 Leiterin des Bereichs Technologie & Innovation und Gesamtprokuristin (seit 2003) in der Austria Wirtschaftsservice GmbH (aws)
2004-2006 Geschäftsführerin der ARGE Impulsprogramm Creativwirtschaft
2008-2010 Stellvertretende Vorsitzende, Universitätsrat Veterinärmedizinische Universität Wien
2009-2010 Aufsichtsrätin Innovacell Biotechnologie AG
2010-2016 Rektorin, Veterinärmedizinische Universität Wien
seit 2010 Aufsichtsrätin Vetwidi Forschungsholding GmbH
seit 2011 Aufsichtsratsvorsitzende Kunsthalle Wien GmbH
seit 2016 Bundesministerin für Bildung und Frauen

LL.B MBA Isaac T. KOHLBERG

Senior Associate Provost and Chief Technology Development Officer, Office of Technology Development, Harvard University, Cambridge

1980 University of Strasbourg, France, Diploma for French Cultural and Historical Studies
1981 INSEAD - Institut Europeen d'Administration aux Affaires, Fountainbleau, France, M.B.A.
1982 Mennen Medical Company Ltd., Tel Aviv, Israel, Marketing Manager
1986-1989 Weizmann Institute of Science, Rehovot, Israel. Managing Director, YEDA Research & Development Co. Ltd.. Led the technology transfer program at the Weizmann Institute of Science where he negotiated multiple joint venture and royalty deals which continue to pay dividends in the multi-million dollar range
1989-1998 Vice President for Industrial Liaison, New York University Medical Center. Established and led the office of Science and Technology Administration at NYU School of Medicine, with responsibility for sponsored programs, research administration, clinical trials and technology transfer
1989-2001 New York University, NY
1994-1998 Associate Dean, Science and Technology Administration, NYU Medical Center
1999-2001 Vice Provost, Vice Dean, Industrial Liaison and Research Administration, NYU School of Medicine Established and led the technology transfer program at New York University, NYU School of Medicine and its affiliated hospitals; established and led NYU School of Medicine s Clinical Trials Development program and guided NYU's participation in and served on the Board of the Biomedical Research Alliance of New York.
2001-2005 Tel Aviv University, Israel. Chief Executive Officer, Ramot and the Economic Corporation reorganized the technology licensing operation, Ramot, at Tel Aviv University. Hired new senior staff managing a total of 28 and recruited the board, made up predominately of industrialists and venture capitalists, to whom Ramot reports. Established and led the Economic Corporation at Tel Aviv University to oversee the revenue generation centers of the University including real estate and technology transfer and the newly formed functions of publishing and E-learning.
since 2005 Harvard University, responsible for the development of translating new knowledge and innovations into practical advances beneficial to society through technology transfer based on discoveries made throughout Harvard University.

Karen LAIGAARD

Director of Technology Transfer, The Tech Transfer Unit, University of Copenhagen

1992-1993 Project Co-ordinator, University of Strathclyde, Glasgow, United Kingdom
1993-1996 Marketing Manager, The British Council Scotland, Glasgow, United Kingdom
1996-2001 International Marketing Manager, Research and Enterprise, University of Glasgow, United Kingdom
2002-2003 Head of Section, Danish Ministry of Science, Technology and Innovation, Copenhagen, Denmark
since 2003 Director of Technology Transfer, University of Copenhagen
2007 Vice-President, Association of European Science and Technology Transfer Professionals (ASTP)

Dr. Egenhard LINK

Senior Patent & Licensing Manager Life Sciences, Max-Planck-Innovation GmbH, Munich

 After his final exams in Biology at the Technical University and Ludwig Maximilians University in Munich, Germany, Egenhard Link accomplished his diploma thesis at the Max Planck Institute of Biochemistry in Martinsried. For his Ph.D. and as a Postdoc he conducted research in the Boyer Center for Molecular Medicine, Howard Hughes Medical Institute, at Yale University in New Haven, Connecticut (USA). Among other things, he elucidated the mechanisms of action of tetanus and botulinum neurotoxins.
 After five years in the United States he returned to Germany to become research associate at the Max Planck Institute for Experimental Medicine in Goettingen and to build up the small albeit profitable start-up company Synaptic Systems. In fall 2000, Egenhard Link joined Max Planck Innovation where he holds the position of Senior Patent and Licensing Manager and is responsible for Technology Transfer of Max Planck Institutes in the field of 'Life Sciences'

Ph.D. Bernard MEUNIER

Member of the French Academy of Sciences; Director General, PALUMED, Labège

1993-2006 Associate Professor at the Ecole Polytechnique, Palaiseau, France
2004-2006 President of the Centre National de la Recherche Scientifique, France (CNRS)
2000 Founder of PALUMED S.A. (4 VC's investors)
2007 President of the CiRFC fondation, University of Strasbourg

Dipl.-Ing. Andreas STINGL

CEO & President, Femtolasers Produktions GmbH, Wien

1994 Co-founder and general manager of 'Stingl OEG', Korneuburg
1997 Co-founder, CEO and President of 'Femtolasers Produktions GmbH', Vienna
2003 Co-founder and director of the board of 'Femtolasers, Inc' Boston, MA

Dr. Dr. h.c. mult. Peter Andreas GRÜNBERG

Nobelpreisträger für Physik; Professor emeritus, Institut für Festkörperforschung, Forschungszentrum Jülich GmbH, Jülich

1963-1969 Continues studies of physics at Darmstadt University of Technology, Germany, diploma 1966, doctor's degree 1969
1969-1972 Postdoctoral Fellow of National Research Council of Canada at Carleton University in Ottawa, Canada
since 1972 Research scientist at the Institute of Solid State Research at Forschungszentrum Jülich, Germany
1984 Habilitation at the University of Cologne, Germany, "Privatdozent"
1984-1985 Research stay at Argonne National Laboratory, Illinois, USA
1986 Activities in the field of antiferromagnetic coupling in Fe/Cr/Fe layers
1988 Work on the GMR effect in Jülich, Germany
1992 Appointment as adjunct professor at the University of Cologne, Germany
1998 Six-month research stay at the University of Sendai and at Tsukuba Research Centre, Japan
2004 After 32 years at Jülich, Germany, Peter Grünberg retires, but continues working
2007 Helmholtz Professorship, Forschungszentrum Jülich, Germany

Ph.D. David MIRELMAN

Professor Emeritus, Department of Biological Chemistry and Former Vice President for Technology Transfer, Weizmann Institute of Science, Rehovot

 *1938 - Buenos Aires, Argentina, Immigrated to Israel 1949
1968 Ph.D. Biochemistry of Bacterial Cell Walls, Weizmann Institute of Science, Rehovot, Israel
1968-1970 Post Doctorate, Tufts University Medical School, Boston, USA
since 1970 Faculty Member, Department of Biological Chemistry, Weizmann Institute of Science
1973 Visiting Scientist, Max-Planck-Institute, Tuebingen
1976 Associate Professor with tenure
1976-1977 University of California, Berkeley
1984 Harvard University, Cambridge, MA
1984 Full Professor, Weizmann Institute
1985 Besen-Brender Chair of Microbiology and Parasitology, Department of Biological Chemistry, Weizmann Institute of Science
1991-1992 Fogarty Scholar, National Institutes of Health, Bethesda, MD
1987-1998 Chairman of the Board of Directors, Yeda Research and Development Co. Ltd.
1989-1992 Member Board of Directors, News Datacom Corp., Jerusalem, Israel
1991-1994 Member Board of Directors, Weizmann Technological Incubator Company
1993-1998 Vice President for Technology Transfer, Weizmann Institute of Science
1995-1998 Member of Board of Directors, XTL Biotechnology, Rehovot, Israel
1996-1998 Member of Board of Directors of Portman Pharmaceuticals, Rehovot, Israel
1999-2004 Dean, Faculty of Biochemistry, Weizmann Institute of Science
1999-2001 President, Israel Society for Microbiology
2004-2012 President of Scientific Council, Conseil I.Pasteur-Weizmann I.
since 2010 Member of Executive Board of Directors, Weizmann Institute of Science

Dipl.-Ing. Dr. Gerald MURAUER

Head of Corporate Technology Central Eastern Europe (CEE), Siemens AG Österreich, Vienna

1999-2001 Studium TU Wien Wirtschaftsingenieurwesen, Dr. Dissertation: Unternehmensgründungen durch Venture Capital
2001-2002 Berater, Boston Consulting Group
2002-2005 Stv. Geschäftsführer, Wiener Wissenschafts- und Technologiefonds
2005-2007 Unternehmersgründer, Murauer & Partner
2007-2012 Managing Director, Institute of Science and Technology Austria (I.S.T. Austria)

Technology Forum

show timetable

21.08.2008

08:00 - 10:30Technology brunch hosted by Tiroler ZukunftsstiftungSocial
11:00 - 11:20Opening by the European Forum AlpbachPlenary
11:20 - 12:00Plenary sessionPlenary
12:00 - 12:30Plenary sessionPlenary
13:00 - 13:45Ethics of sciencePlenary
13:45 - 14:30Stem cellsPlenary
15:00 - 16:00Politics and science – Advice through sciencePlenary
18:00 - 19:30BionicsPlenary
19:30 - 21:30Reception hosted by Alcatel-Lucent Austria AGSocial

22.08.2008

07:00 - 14:00Working Group 01: From basic research to economic valueBreakout
07:00 - 14:00Working Group 02: Research integrity in scienceBreakout
07:00 - 14:00Working Group 03: The myths of life sciences and their consequencesBreakout
07:00 - 14:00Working Group 04: Aviation and the environmentBreakout
07:00 - 14:00Working Group 05: Think Tanks in AustriaBreakout
07:00 - 14:00Working Group 06: Gender mainstreaming in science and development. Perceive realities and decide visionarilyBreakout
07:00 - 14:00Working Group 07: Success factor human resources – Regions in competitionBreakout
07:00 - 14:00Working Group 08: Climate change – The future of transportBreakout
07:00 - 14:00Working Group 09: The governance of applied research: responsibilities, independence and resourcesBreakout
07:00 - 14:00Working Group 10: Digital healthcareBreakout
07:00 - 16:00Junior Alpbach – Science and technology for young peopleBreakout
07:00 - 13:00Ö1 Children’s University Alpbach – Science and technology for kidsBreakout
08:00 - 14:00Working Group 11: Energy efficiency – Recognizing opportunities, utilizing potentialsBreakout
08:00 - 13:00Special Event: From the Stability Pact for South Eastern Europe to the Regional Cooperation Council – A New Momentum for the Western Balkans’ Perspective in Higher Education and Research?Breakout
14:30 - 15:15The frontiers of science, part IPlenary
15:15 - 16:30Global competition for global talentsPlenary
18:00 - 19:30Information and communications infrastructures – The nerve centres of modern societiesPlenary

23.08.2008

08:00 - 08:30Science education for a science-driven societyPlenary
08:30 - 09:15The frontiers of science, part IIPlenary
09:15 - 09:45The future of the environment and agriculturePlenary
10:00 - 10:15Junior Alpbach and Ö1 Children’s University Alpbach 2008Plenary
10:15 - 11:15Improbable Research and the Ig Nobel prizePlenary
11:15 - 12:00Snack reception, hosted by AVL List GmbHSocial